Nearly 1M Gastric Cancer Cases in 2024: 76% Linked to Treatable H. pylori, IARC Data Shows

New global estimates show nearly one million people developed gastric cancer in 2024 and about 650,000 died, with roughly three-quarters of cases linked to a treatable bacterial infection, according to IARC data released for Gastric Cancer Awareness Month.

On November 3, the International Agency for Research on Cancer (IARC) published its latest incidence and mortality estimates for 2024, showing gastric cancer ranked fifth worldwide in both new cases and cancer deaths, Oncodaily reported. About two-thirds of cases and deaths occurred among men, and Asia bore the greatest burden, with China alone accounting for more than one-third of global cases and deaths.

How many cases are linked to H. pylori?

Approximately 760,000 of the 2024 cases — roughly 76 percent — were attributable to Helicobacter pylori infection, IARC estimated. The bacterium is classified as a Group 1 carcinogen, meaning there is sufficient evidence it causes cancer in humans. Most people infected never develop gastric cancer, but persistent infection can trigger a decades-long sequence of precancerous changes known as the Correa cascade, progressing from chronic gastritis to atrophy, intestinal metaplasia, dysplasia, and eventually adenocarcinoma.

What symptoms should prompt medical assessment?

Early-stage disease often produces few or no symptoms. When they appear, they can mimic common digestive problems. Persistent upper abdominal discomfort, unexplained weight loss, loss of appetite, early satiety, persistent nausea or vomiting, difficulty swallowing, and gastrointestinal bleeding are possible manifestations, according to Oncodaily – Oncology News, Insights, Stories.

Dr Rajesh Mistry, Senior Director of Oncology at Kokilaben Dhirubhai Ambani Hospital in Mumbai, said people should pay attention to digestive changes that persist rather than repeatedly treating them as routine acidity, Firstpost reported. “Frequent indigestion or heartburn, especially when accompanied by discomfort in the upper abdomen, may indicate an underlying stomach problem if it does not improve with routine treatment,” said Dr Vishnu Hari, Associate Director and Head of Medical Oncology at Sarvodaya Hospital in Faridabad, Firstpost reported.

How is gastric cancer diagnosed?

Upper gastrointestinal endoscopy with biopsy is the central diagnostic test when gastric cancer is suspected. Imaging such as CT scans, endoscopic ultrasound, PET/CT, or diagnostic laparoscopy helps determine disease extent.

Biomarker testing for HER2, PD-L1, MSI/dMMR, and CLDN18.2 may guide treatment decisions when clinically appropriate. H. pylori can be detected by urea breath tests, stool antigen tests, or biopsy-based methods, but a positive test does not mean a patient has cancer.

Where did Gastric Cancer Awareness Month originate?

The observance traces to No Stomach For Cancer (NSFC), a nonprofit founded in 2009. In 2010, NSFC worked with the U.S. Senate to pass Senate Resolution 655, introduced by Senator Russ Feingold and co-sponsored by Senator Dick Durbin, designating November 2010 as Gastric Cancer Awareness Month. The timing aligns with Thanksgiving.

November highlights three major cancer challenges

November also marks Lung Cancer Awareness Month and Pancreatic Cancer Awareness Month, highlighting three major global cancer challenges that share an urgent need for earlier diagnosis, continued scientific progress, and improved patient outcomes, Oncodaily reported.